Scalability of novel therapies
Organised by the NBV working group Biopharma
When: Wednesday 23 November 2022
Where: uniQure, Amsterdam
Registration is free of charge for NBV members.
|18:00||Registration , Coffee & Sandwiches|
|18:30||Opening by Session Chairs|
|18:35||Applying the AdVac ® platform to development of a COVID 19 vaccine
Marcel de Vocht, Scientific Director Process Development | Janssen Vaccines
|19:05|| Virus-like particle vaccines from insect cells: Development of a COVID-19 vaccine
Jort Altenburg, PhD student | Wageningen University
High throughput scale down model for fast USP development in gene therapy
|20:30||Closing & Drinks|
The programme is chaired by Lenneke de Winter and Michel Eppink.
Checkout the program abstracts, directions and parking and more information about the program here.